DeepMed Research

UNIVERSITY OF CALIFORNIA, IRVINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1965-01-01

Employees: 10K

Market Cap: -

Website: http://www.uci.edu

Clinical Trials

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Phase 2

Recruiting

Conditions: Hepatocellular Carcinoma
HCC

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Drug: Cabozantinib
Procedure: Transarterial Chemoembolization

First Posted Date: 2020-07-15

Last Posted Date: 2025-04-30

Lead Sponsor: University of California, Irvine

Target Recruit Count: 35

Registration Number: NCT04472767

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

Emotion-Diet Interactions in Pregnancy

Not Applicable

Completed

Conditions: Emotional Stress
Stress, Psychological
Glucose Intolerance During Pregnancy
Insulin Sensitivity/Resistance
Pregnancy Related
Postprandial Hyperglycemia

Interventions: Behavioral: Psychosocial stress
Behavioral: Control non-stress

First Posted Date: 2020-06-12

Last Posted Date: 2024-05-09

Lead Sponsor: University of California, Irvine

Target Recruit Count: 113

Registration Number: NCT04430439

Locations: 🇺🇸
UCI Medical Center, University of California, Irvine, Orange, California, United States
🇺🇸
University of California, Irvine, Irvine, California, United States

Treatment of Tinnitus With Migraine Medications

Phase 4

Recruiting

Conditions: Tinnitus
Tinnitus, Subjective

Interventions: Drug: Verapamil + paroxetine
Other: Placebo
Drug: Nortriptyline + topiramate

First Posted Date: 2020-05-27

Last Posted Date: 2023-01-09

Lead Sponsor: University of California, Irvine

Target Recruit Count: 150

Registration Number: NCT04404439

Locations: 🇺🇸
University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange, California, United States

HOPE Intervention for COVID-19

Not Applicable

Completed

Conditions: COVID-19 Vaccination

Interventions: Behavioral: HOPE intervention

First Posted Date: 2020-05-06

Last Posted Date: 2025-05-02

Lead Sponsor: University of California, Irvine

Target Recruit Count: 120

Registration Number: NCT04376515

Locations: 🇺🇸
UC Irvine, Irvine, California, United States

Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo

Not Applicable

Terminated

Conditions: Vitiligo

Interventions: Device: MKTP with Negative Pressure Instrument
Procedure: MKTP with Surgical blade
Device: Suction blister grafting without cell dissociation

First Posted Date: 2020-05-05

Last Posted Date: 2023-07-18

Lead Sponsor: University of California, Irvine

Target Recruit Count: 17

Registration Number: NCT04374435

Locations: 🇺🇸
University of California, Irvine, Irvine, California, United States

Skin Imaging to Inform Laser Treatments

Not Applicable

Terminated

Conditions: Angioma
Port-Wine Stain
Rosacea
Telangiectasia

Interventions: Device: Optical Coherence Tomography

First Posted Date: 2020-04-07

Last Posted Date: 2024-01-30

Lead Sponsor: University of California, Irvine

Target Recruit Count: 55

Registration Number: NCT04336163

Locations: 🇺🇸
University of California, Irvine, Irvine, California, United States

Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer

Phase 2

Terminated

Conditions: Breast Neoplasm
Hormone Receptor Positive Breast Carcinoma

Interventions: Drug: Abemaciclib
Drug: Fulvestrant

First Posted Date: 2020-03-12

Last Posted Date: 2023-06-06

Lead Sponsor: University of California, Irvine

Target Recruit Count: 1

Registration Number: NCT04305236

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

BCI-FES Therapy for Stroke Rehabilitation

Not Applicable

Active, not recruiting

Conditions: Ischemic Stroke
Hemorrhagic Stroke

Interventions: Behavioral: Physiotherapy two hours
Device: BCI-FES dorsiflexion therapy
Behavioral: Physiotherapy one hour

First Posted Date: 2020-02-20

Last Posted Date: 2024-10-11

Lead Sponsor: University of California, Irvine

Target Recruit Count: 66

Registration Number: NCT04279067

Locations: 🇺🇸
University of California, Irvine - Sue & Bill Gross Stem Cell Research Center, Irvine, California, United States

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

Phase 2

Active, not recruiting

Conditions: Acute Myelogenous Leukemia (AML) Due to Therapy
Acute Myeloid Leukemia With Myelodysplasia-Related Changes

Interventions: Drug: Glasdegib
Drug: CPX-351

First Posted Date: 2020-01-18

Last Posted Date: 2024-08-26

Lead Sponsor: University of California, Irvine

Target Recruit Count: 30

Registration Number: NCT04231851

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

and more 1 locations

Evaluation of a Crowd-Powered Web Platform for Depression and Anxiety

Not Applicable

Completed

Conditions: Depression, Anxiety

Interventions: Behavioral: ADAPT Platform (Treatment)
Behavioral: ADAPT Comparison (Control)

First Posted Date: 2020-01-13

Last Posted Date: 2023-06-29

Lead Sponsor: University of California, Irvine

Target Recruit Count: 107

Registration Number: NCT04226742

Locations: 🇺🇸
University of California Irvine, Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy